BioSpace News Archive

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that Health Canada has approved the use of Moderna’s mRNA COVID-19 vaccine, SPIKEVAX™, in a two-dose series of 25 µg per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years.

SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced the addition of Louis Pace as Chief Financial Officer and Chief Information Officer.

The latest market analysis report published by Reports and Data, titled ‘Global Leupeptin Market – Forecast to 2030,’ thoroughly examines the Leupeptin industry to provide essential data & information for the targeted readers.

The global transplantation market size is expected to reach USD 32.94 Billion in 2030 and register a revenue CAGR of 11.5% over the forecast period, according to the latest report by Reports and Data.

Seer Inc., a life sciences company commercializing a disruptive new platform for proteomics, announced it will report financial results for the second quarter of 2022 on Tuesday, August 9, 2022.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, July 29, 2022 to discuss its second quarter 2022 operating results.

Champions Oncology, Inc., a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the fourth quarter ended April 30, 2022, on Thursday, July 21, 2022, after market close.

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2022 following the close of market on Thursday, August 11, 2022.

Blueprint Medicines Corporation (NASDAQ: BPMC) today published its first Corporate Responsibility Report.

Following a comprehensive search process, 10x Genomics, Inc., announced the hiring of Jim Wilbur, Ph.D., as Chief Commercial Officer, effective July 27.